![Ki-Young Son](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ki-Young Son
Chief Executive Officer at
ENZYCHEM LIFESCIENCES CORPORATION
Net worth: 3 M $ as of 2026-03-30
Profile
Ki-Young Son has been Chairman & Chief Executive Officer at ENZYCHEM LIFESCIENCES Corp.
since 2012.
Mr. Son has been Chairman at Bridget Lifesciences Corp.
since 2003.
Son completed undergraduate and graduate degrees at Korea University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-07-22 | 4,069,430 ( 4.78% ) | 3 M $ | 2026-03-30 |
Ki-Young Son active positions
| Companies | Position | Start |
|---|---|---|
| ENZYCHEM LIFESCIENCES CORPORATION | Chief Executive Officer | 2012-05-31 |
Bridget Lifesciences Corp.
 Bridget Lifesciences Corp. Financial ConglomeratesFinance Functions as an investment holding company | Chairman | 2002-12-31 |
Training of Ki-Young Son
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
21
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Korea University
 Korea University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ENZYCHEM LIFESCIENCES Corp.
 ENZYCHEM LIFESCIENCES Corp. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Bridget Lifesciences Corp.
Bridget Lifesciences Corp. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
- Stock Market
- Insiders
- Ki-Young Son
